A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer
Clinical trial NCT02742051 · COMPLETED
Trial details
- NCT number
- NCT02742051
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2020-03-14
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.